Cell Therapy Consumables

Chapter Outlines

Chapter 2 is an executive summary of key insights captured in our research. It offers a high-level view on the current state of the cell therapy consumables market and its likely evolution in the short to mid-term and long-term.

Chapter 3 provides a general introduction to cell therapies. It further includes a detailed discussion on the development and manufacturing process of cell therapies, along with information on the role of raw materials in cell therapy manufacturing. Furthermore, it provides a brief overview of the different types of cell therapy consumables and key challenges associated with their development.

Chapter 4 provides a detailed overview of the cell therapy consumables landscape. It includes information related to over 60 industry players that are currently active in this domain. In addition, it features an in-depth analysis of the market, based on a number of parameters, such as year of establishment, company size, location of headquarters, location of consumable facilities, type of consumable (kits, media and reagents), type of cell therapy (dendritic cell therapy, NK cell therapy, stem cell therapy and T-cell therapy), application area (research use and therapeutic use), scale of operation (preclinical, clinical and commercial) and type of end-user (industry and non-industry).

Chapter 5 features an insightful company competitiveness analysis, highlighting prominent consumable service providers, taking into consideration service strength of a company (based on its experience and company size), product portfolio (number of type of consumable, number of unique type of cell therapy, number of consumable facilities and application area) and number of products.

Chapter 6 provides an elaborative brand positioning analysis of the leading industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.

Chapter 7 provides elaborate profiles of key service providers (shortlisted on the basis of the company competitiveness analysis) engaged in this domain. Each profile features a brief overview of the company, details related to cell therapy consumable focused product portfolio, consumable facilities, recent developments and an informed future outlook.

Chapter 8 provides detailed analysis of the recent developments and initiatives (partnerships and collaborations, mergers and acquisitions and expansions) that have been undertaken in the cell therapy consumable industry, during the period between 2016 and 2021.

Chapter 9 features an in-depth analysis of over 310 cell therapy developers that are anticipated to partner with cell therapy consumable providers. These players have been shortlisted based on several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), manufacturing facilities and availability of other cell therapy capabilities.

Chapter 10 provides an informed estimate of the annual demand for cell therapy consumables (in terms of volume of media required for total number of cells), based on type of cell therapy and key geographical regions.

Chapter 11 presents an insightful market forecast analysis, highlighting the future potential of cell therapy consumables market till 2031. We have segmented the market on the basis of [A] type of consumable (kits, media and reagents), [B] type of cell therapy (dendritic cell therapy, NK cell therapy, stem cell therapy and T-cell therapy), [C] scale of operation (clinical and commercial), [D] type of end-user (industry and non-industry) and [E] key geographical regions (North America, Europe, Asia-Pacific and Rest of the World).

Chapter 12 features an elaborate discussion on the future opportunities / trends within the cell therapy consumables market that are likely to influence the growth of this domain over the coming years.

Chapter 13 highlights the effects of the recent COVID-19 pandemic on the consumables market for cell therapies, along with information on the key initiatives undertaken by various service providers in order to overcome the challenges faced due to the pandemic.

Chapter 14 is a summary of the entire report. It provides the key takeaways and presents our independent opinion of the cell therapy consumables market, based on the research and analysis described in the previous chapters. 

Chapter 15 is a collection of transcripts of interviews conducted with various stakeholders in the industry. 

Chapter 16 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY
2.1. Chapter Overview

3. INTRODUCTION
3.1. Context and Background
3.2. Chapter Overview
3.3. Introduction to Cell Therapies
3.3.1. Comparison of Cell Therapies and Other Biotechnology Products
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development
3.7. Type of Cell Therapy Consumable
3.8. Key Challenges Associated with Cell Therapy Consumables
3.9. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell Therapy Kit Providers: List of Players
4.2.1. Analysis by Year of Establishment 
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kits Preparation Facilities
4.2.5. Analysis by Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Scale of Operation
4.2.10. Analysis by Application Area
4.2.11. Analysis by Application Area and Geography (Regional Landscape)

4.3. Cell Therapy Media Providers: List of Players
4.3.1. Analysis by Year of Establishment 
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Preparation Facilities
4.3.5. Analysis by Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Components
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Scale of Operation
4.3.11. Analysis by Application Area
4.3.12. Analysis by Application Area and Geography (Regional Landscape)

4.4. Cell Therapy Reagent Providers: List of Players
4.4.1. Analysis by Year of Establishment 
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Preparation Facilities
4.4.5. Analysis by Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Scale of Operation
4.4.10. Analysis by Application Area
4.4.11. Analysis by Application Area and Geography (Regional Landscape)
4.5. Analysis by Type of Consumable, Type of Cell Therapy and Application Area (Grid Representation)

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Company Competitiveness: Kit Providers
5.5. Company Competitiveness: Media Providers
5.6. Company Competitiveness: Reagent Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview 
6.2. Scope and Methodology
6.3. Bio-Techne
6.4. Miltenyi Biotec
6.5. Sartorius
6.6. STEMCELL Technologies
6.7. Thermo Fisher Scientific

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Miltenyi Biotec
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook

7.3. STEMCELL Technologies
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook

7.4. Bio-Techne
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook

7.5. Irvine Scientific
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook

7.6. Thermo Fisher Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook

7.7. Sartorius
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook

7.8. BD Biosciences
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook

7.9. Lonza
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook

7.10. CellGenix
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook

7.11. Corning
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES 
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Recent Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Consumable
8.3.5. Analysis by Type of Partnership and Type of Consumable
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Consumable and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships 
8.3.9. Analysis by Region
8.3.9.1. Intracontinental and Intercontinental Agreements
8.3.9.2. Local and International Agreements

8.3.10. Cumulative Year-wise Trend of Merger / Acquisition
8.3.11. Analysis by Type of Acquisition
8.3.12. Analysis by Key Value Drivers
8.3.13. Analysis by Year of Acquisition and Key Value Drivers

8.4. Cell Therapy Consumables: Recent Expansions
8.4.1. Analysis by Year of Expansion
8.4.2. Analysis by Purpose of Expansion
8.4.3. Analysis by Year and Purpose of Expansion
8.4.4. Analysis by Type of Consumable
8.4.5. Analysis by Purpose of Expansion and Type of Consumable
8.4.6. Analysis by Area of Expansion
8.4.7. Analysis by Region 
8.4.7.1. Analysis by Location of Consumable Facility (Continent-wise)
8.4.7.2. Analysis by Location of Consumable Facility (Country-wise)
8.4.8. Analysis by Purpose of Expansion and Location of Headquarters

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS   
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions 
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.3.1. Likely Partner Opportunities for Dendritic Cell Therapy Consumable Providers
9.3.2. Likely Partner Opportunities for NK Cell Therapy Consumable Providers 
9.3.3. Likely Partner Opportunities for Stem Cell Therapy Consumable Providers 
9.3.4. Likely Partner Opportunities for T-Cell Therapy Consumable Providers 

10. DEMAND ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Demand for Cell Therapy Consumables
10.4. Global Demand for Cell Therapy Consumables for Planar Processes
10.5. Global Demand for Cell Therapy Consumables for Suspension Processes
10.6. Analysis by Scale of Operation
10.7. Analysis by Region 

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology
11.3. Global Outsourced Cell Therapy Consumables Market, 2021-2031

11.4. Outsourced Cell Therapy Consumables Market, 2021-2031: Distribution by Type of Consumable
11.4.1. Outsourced Cell Therapy Consumables Market for Kits, 2021-2031
11.4.2. Outsourced Cell Therapy Consumables Market for Media, 2021-2031
11.4.3. Outsourced Cell Therapy Consumables Market for Reagents, 2021-2031

11.5. Outsourced Cell Therapy Consumables Market, 2021-2031: Distribution by Type of Cell Therapy
11.5.1. Outsourced Cell Therapy Consumables Market for Dendritic Cell Therapy, 2021-2031
11.5.2. Outsourced Cell Therapy Consumables Market for NK Cell Therapy, 2021-2031
11.5.3. Outsourced Cell Therapy Consumables Market for Stem Cell Therapy, 2021-2031
11.5.4. Outsourced Cell Therapy Consumables Market for T-Cell Therapy, 2021-2031
11.6. Outsourced Cell Therapy Consumables Market, 2021-2031: Distribution by Scale of Operation
11.6.1. Outsourced Cell Therapy Consumables Market for Clinical Operations, 2021-2031
11.6.2. Outsourced Cell Therapy Consumables Market for Commercial Operations, 2021-2031

11.7. Outsourced Cell Therapy Consumables Market, 2021-2031: Distribution by Type of End-User
11.7.1. Outsourced Cell Therapy Consumables Market for Industry Players, 2021-2031
11.7.2. Outsourced Cell Therapy Consumables Market for Non-Industry Players, 2021-2031

11.8. Outsourced Cell Therapy Consumables Market, 2021-2031: Distribution by Geography
11.8.1. Outsourced Cell Therapy Consumables Market in North America, 2021-2031
11.8.2. Outsourced Cell Therapy Consumables Market in Europe, 2021-2031
11.8.3. Outsourced Cell Therapy Consumables Market in Asia-Pacific, 2021-2031
11.8.4. Outsourced Cell Therapy Consumables Market in Rest of the World, 2021-2031

12. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
12.1. Chapter Overview
12.2. Emerging Trends Related to Cell Culture Media
12.3. Automation of Cell Therapy Manufacturing Processes 
12.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

13. IMPACT OF COVID-19 ON CELL THERAPY CONSUMABLES MARKET
13.1. Chapter Overview
13.2. Impact of COVID-19 Pandemic on Cell Therapy Consumables Market
13.3. Impact on Future Market Opportunities for Cell Therapy Consumable Providers
13.4. Current Opinions and Key Initiatives of Key Players
13.5. Recuperative Strategies for Developer Businesses
13.5.1. Strategies for Implementation in the Short / Mid Term
13.5.2. Strategies for Implementation in the Long Term

14. CONCLUDING REMARKS
14.1. Chapter Overview

15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Anant Kamath, Chief Operating Officer, Cellular Engineering Technologies
15.2.1. Cellular Engineering Technologies: Key Highlights
15.2.2. Interview Transcript
15.3. Vishal G. Warke, Director R&D, Cell Culture and Immunology, HiMedia Laboratories and Gauri W. Page, Assistant R&D Manager, Animal Cell Culture, Himedia Laboratories
15.3.1. HiMedia Laboratories: Key Highlights
15.3.2. Interview Transcript

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Recent Developments
Figure 2.3 Executive Summary: Demand Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Type of Cell Therapy Consumable
Figure 4.1 Cell Therapy Consumables: Distribution by Type of Consumable
Figure 4.2 Cell Therapy Kit Providers: Distribution by Year of Establishment
Figure 4.3 Cell Therapy Kit Providers: Distribution by Company Size
Figure 4.4 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Kit Preparation Facilities
Figure 4.6 Cell Therapy Kit Providers: Distribution by Accreditations Received
Figure 4.7 Cell Therapy Kit Providers: Distribution by Type of End-User
Figure 4.8 Cell Therapy Kits: Distribution by Type of Cell Therapy
Figure 4.9 Cell Therapy Kits: Distribution by Type of Function
Figure 4.10 Cell Therapy Kits: Distribution by Scale of Operation
Figure 4.11 Cell Therapy Kits: Distribution by Application Area
Figure 4.12 Regional Landscape: Distribution of Kit Providers by Application Area and Geography
Figure 4.13 Cell Therapy Media Providers: Distribution by Year of Establishment
Figure 4.14 Cell Therapy Media Providers: Distribution by Company Size
Figure 4.15 Cell Therapy Media Providers: Distribution by Location of Headquarters
Figure 4.16 Cell Therapy Media Providers: Distribution by Location of Media Preparation Facilities
Figure 4.17 Cell Therapy Media Providers: Distribution by Accreditations Received
Figure 4.18 Cell Therapy Media Providers: Distribution by Type of End-User
Figure 4.19 Cell Therapy Media: Distribution by Type of Cell Therapy
Figure 4.20 Cell Therapy Media: Distribution by Media Components
Figure 4.21 Cell Therapy Media: Distribution by Type of Function
Figure 4.22 Cell Therapy Media: Distribution by Scale of Operation
Figure 4.23 Cell Therapy Media: Distribution by Application Area
Figure 4.24 Regional Landscape: Distribution of Media providers by Application Area and Geography
Figure 4.25 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Figure 4.26 Cell Therapy Reagent Providers: Distribution by Company Size
Figure 4.27 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Figure 4.28 Cell Therapy Reagent Providers: Distribution by Location of Reagent Preparation Facilities
Figure 4.29 Cell Therapy Reagent Providers: Distribution by Accreditations Received
Figure 4.30 Cell Therapy Reagent Providers: Distribution by Type of End-User
Figure 4.31 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Figure 4.32 Cell Therapy Reagents: Distribution by Type of Function
Figure 4.33 Cell Therapy Reagents: Distribution by Scale of Operation
Figure 4.34 Cell Therapy Reagents: Distribution by Application Area
Figure 4.35 Regional Landscape: Distribution of Reagent Providers by Application Area and Geography
Figure 4.36 Grid Representation: Distribution by Type of Consumable, Type of Cell Therapy and Application Area
Figure 5.1 Company Competitiveness: Cell Therapy Kit Providers
Figure 5.2 Company Competitiveness: Cell Therapy Media Providers
Figure 5.3 Company Competitiveness: Cell Therapy Reagent Providers
Figure 6.1 Brand Positioning Matrix: Bio-Techne
Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec  
Figure 6.3 Brand Positioning Matrix: Sartorius 
Figure 6.4 Brand Positioning Matrix: STEMCELL Technologies
Figure 6.5 Brand Positioning Matrix: Thermo Fisher Scientific 
Figure 7.1 Miltenyi Biotec: Product Portfolio
Figure 7.2 STEMCELL Technologies: Product Portfolio
Figure 7.3 Bio-Techne: Product Portfolio
Figure 7.4 Irvine Scientific: Product Portfolio
Figure 7.5 Thermo Fisher Scientific: Product Portfolio
Figure 7.6 Sartorius: Product Portfolio
Figure 7.7 BD Biosciences: Product Portfolio
Figure 7.8 Lonza: Product Portfolio
Figure 7.9 CellGenix: Product Portfolio
Figure 7.10 Corning: Product Portfolio
Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Consumable
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Consumable and Type of Cell Therapy
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 8.10 Partnerships and Collaborations: Local and International Agreements
Figure 8.11 Mergers and Acquisitions: Year-wise Cumulative Trend, 2016-2021
Figure 8.12 Mergers and Acquisitions: Distribution by Type of Acquisition
Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.15 Recent Expansions: Distribution by Year of Expansion
Figure 8.16 Recent Expansions: Distribution by Purpose of Expansion
Figure 8.17 Recent Expansions: Distribution by Year and Purpose of Expansion
Figure 8.18 Recent Expansions: Distribution by Type of Consumable
Figure 8.19 Recent Expansions: Distribution by Purpose of Expansion and Type of Consumable
Figure 8.20 Recent Expansions: Distribution by Area of Expansion
Figure 8.21 Recent Expansions: Distribution by Location of Consumable Facility (Continent-wise)
Figure 8.22 Recent Expansions: Distribution by Location of Consumable Facility (Country-wise)
Figure 8.23 Recent Expansions: Distribution by Location of Headquarters and Purpose of Expansion
Figure 10.1 Global Demand for Cell Therapy Consumables, 2021-2026 (Million Liters)
Figure 10.2 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026 (Million Liters)
Figure 10.3 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026 (Million Liters)
Figure 10.4 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Figure 10.5 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Figure 10.6 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Region (Million Liters)
Figure 10.7 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Region (Million Liters)
Figure 11.1 Global Outsourced Cell Therapy Consumables Market, 2021-2031 (USD Million)
Figure 11.2 Outsourced Cell Therapy Consumables Market: Distribution by Type of Consumable
Figure 11.3 Outsourced Cell Therapy Consumables Market for Kits, 2021-2031 (USD Million)
Figure 11.4 Outsourced Cell Therapy Consumables Market for Media, 2021-2031 (USD Million)
Figure 11.5 Outsourced Cell Therapy Consumables Market for Reagents, 2021-2031 (USD Million)
Figure 11.6 Outsourced Cell Therapy Consumables Market: Distribution by Type of Cell Therapy
Figure 11.7 Outsourced Cell Therapy Consumables Market for Dendritic Cell Therapy, 2021-2031 (USD Million)
Figure 11.8 Outsourced Cell Therapy Consumables Market for NK Cell Therapy, 2021-2031 (USD Million)
Figure 11.9 Outsourced Cell Therapy Consumables Market for Stem Cell Therapy, 2021-2031 (USD Million)
Figure 11.10 Outsourced Cell Therapy Consumables Market for T-Cell Therapy, 2021-2031 (USD Million)
Figure 11.11 Outsourced Cell Therapy Consumables Market: Distribution by Scale of Operation
Figure 11.12 Outsourced Cell Therapy Consumables Market for Clinical Operations, 2021-2031 (USD Million)
Figure 11.13 Outsourced Cell Therapy Consumables Market for Commercial Operations, 2021-2031 (USD Million)
Figure 11.14 Outsourced Cell Therapy Consumables Market: Distribution by Type of End-User
Figure 11.15 Outsourced Cell Therapy Consumables Market for Industry Players, 2021-2031 (USD Million)
Figure 11.16 Outsourced Cell Therapy Consumables Market for Non-Industry Players, 2021-2031 (USD Million)
Figure 11.17 Outsourced Cell Therapy Consumables Market: Distribution by Region
Figure 11.18 Outsourced Cell Therapy Consumables Market in North America, 2021-2031 (USD Million)
Figure 11.19 Outsourced Cell Therapy Consumables Market in Europe, 2021-2031 (USD Million)
Figure 11.20 Outsourced Cell Therapy Consumables Market in Asia-Pacific, 2021-2031 (USD Million)
Figure 11.21 Outsourced Cell Therapy Consumables Market in Rest of the World, 2021-2031 (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Overview
Figure 14.2 Concluding Remarks: Recent Developments
Figure 14.3 Concluding Remarks: Demand Analysis
Figure 14.4 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 14.5 Concluding Remarks: Market Sizing and Opportunity Analysis

List Of Tables

Table 3.1 Cell Therapies: Applications
Table 3.2 Differences between Cell Therapy and Biotechnology Product
Table 3.3 Key Cell Therapy Manufacturing Steps
Table 3.4 Types of Media Used in Cell Therapy Manufacturing
Table 7.1 Miltenyi Biotec: Key Highlights
Table 7.2 Miltenyi Biotec: Product Portfolio
Table 7.3 STEMCELL Technologies: Key Highlights
Table 7.4 STEMCELL Technologies: Product Portfolio
Table 7.5 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.6 Bio-Techne: Key Highlights
Table 7.7 Bio-Techne: Product Portfolio
Table 7.8 Bio-Techne: Recent Developments and Future Outlook
Table 7.9 Irvine Scientific: Key Highlights
Table 7.10 Irvine Scientific: Product Portfolio
Table 7.11 Irvine Scientific: Recent Developments and Future Outlook
Table 7.12 Thermo Fisher Scientific: Key Highlights
Table 7.13 Thermo Fisher Scientific: Product Portfolio
Table 7.14 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.15 Sartorius: Key Highlights
Table 7.16 Sartorius: Product Portfolio
Table 7.17 Sartorius: Recent Developments and Future Outlook
Table 7.18 BD Biosciences: Key Highlights
Table 7.19 BD Biosciences: Product Portfolio
Table 7.20 Lonza: Key Highlights
Table 7.21 Lonza: Product Portfolio
Table 7.22 CellGenix: Key Highlights
Table 7.23 CellGenix: Product Portfolio
Table 7.24 CellGenix: Recent Developments and Future Outlook
Table 7.25 Corning: Key Highlights
Table 7.26 Corning: Product Portfolio
Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, 2016-2021
Table 8.2 Cell Therapy Consumables Partnerships and Collaborations: Information on Type of Agreement (Region-wise and Geography-wise), 2016-2021
Table 8.3 Mergers and Acquisitions: Information on Key Value Drivers, 2016-2021
Table 8.4 Cell Therapy Consumables: List of Recent Expansions, 2016-2021
Table 9.1 Key Potential Strategic Partners for Cell Therapy Consumable Providers
Table 9.2 Likely Partners for Dendritic Cell Therapy Consumable Providers
Table 9.3 Likely Partners for NK Cell Therapy Consumable Providers
Table 9.4 Likely Partners for Stem Cell Therapy Consumable Providers
Table 9.5 Likely Partners for T-Cell Therapy Consumable Providers
Table 15.1 Cellular Engineering Technologies: Key Highlights
Table 15.2 HiMedia Laboratories: Key Highlights
Table 16.1 Cell Therapy Consumables: Distribution by Type of Consumable
Table 16.2 Cell Therapy Kit Providers: Distribution by Year of Establishment
Table 16.3 Cell Therapy Kit Providers: Distribution by Company Size
Table 16.4 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Kit Preparation Facilities
Table 16.6 Cell Therapy Kit Providers: Distribution by Accreditations Received
Table 16.7 Cell Therapy Kit Providers: Distribution by Type of End-User
Table 16.8 Cell Therapy Kits: Distribution by Type of Cell Therapy
Table 16.9 Cell Therapy Kits: Distribution by Type of Function
Table 16.10 Cell Therapy Kits: Distribution by Scale of Operation
Table 16.11 Cell Therapy Kits: Distribution by Application Area
Table 16.12 Cell Therapy Media Providers: Distribution by Year of Establishment
Table 16.13 Cell Therapy Media Providers: Distribution by Company Size
Table 16.14 Cell Therapy Media Providers: Distribution by Location of Headquarters
Table 16.15 Cell Therapy Media Providers: Distribution by Location of Media Preparation Facilities
Table 16.16 Cell Therapy Media Providers: Distribution by Accreditations Received
Table 16.17 Cell Therapy Media Providers: Distribution by Type of End-User
Table 16.18 Cell Therapy Media: Distribution by Type of Cell Therapy
Table 16.19 Cell Therapy Media: Distribution by Media Components
Table 16.20 Cell Therapy Media: Distribution by Type of Function
Table 16.21 Cell Therapy Media: Distribution by Scale of Operation
Table 16.22 Cell Therapy Media: Distribution by Application Area
Table 16.23 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Table 16.24 Cell Therapy Reagent Providers: Distribution by Company Size
Table 16.25 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Table 16.26 Cell Therapy Reagent Providers: Distribution by Location of Reagent Preparation Facilities
Table 16.27 Cell Therapy Reagent Providers: Distribution by Accreditations Received
Table 16.28 Cell Therapy Reagent Providers: Distribution by Type of End-User
Table 16.29 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Table 16.30 Cell Therapy Reagents: Distribution by Type of Function
Table 16.31 Cell Therapy Reagents: Distribution by Scale of Operation
Table 16.32 Cell Therapy Reagents: Distribution by Application Area
Table 16.33 Partnerships and Collaborations: Distribution by Year of Partnership
Table 16.34 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.35 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 16.36 Partnerships and Collaborations: Distribution by Type of Consumable
Table 16.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Table 16.38 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Table 16.39 Partnerships and Collaborations: Distribution by Type of Consumable and Type of Cell Therapy
Table 16.40 Most Active Players: Distribution by Number of Partnerships
Table 16.41 Partnerships and Collaborations: Local and International Agreements
Table 16.42 Mergers and Acquisitions: Year-wise Cumulative Trend, 2016-2021
Table 16.43 Mergers and Acquisitions: Distribution by Type of Acquisition
Table 16.44 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 16.45 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Table 16.46 Recent Expansions: Distribution by Year of Expansion
Table 16.47 Recent Expansions: Distribution by Purpose of Expansion
Table 16.48 Recent Expansions: Distribution by Year and Purpose of Expansion
Table 16.49 Recent Expansions: Distribution by Type of Consumable
Table 16.50 Recent Expansions: Distribution by Purpose of Expansion and Type of Consumable
Table 16.51 Recent Expansions: Distribution by Area of Expansion
Table 16.52 Recent Expansions: Distribution by Location of Consumable Facility (Continent-wise)
Table 16.53 Recent Expansions: Distribution by Location of Consumable Facility (Country-wise)
Table 16.54 Recent Expansions: Distribution by Location of Headquarters and Purpose of Expansion
Table 16.55 Global Demand for Cell Therapy Consumables, 2021-2026 (Million Liters)
Table 16.56 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026 (Million Liters)
Table 16.57 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026 (Million Liters)
Table 16.58 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Table 16.59 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Table 16.60 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Region (Million Liters)
Table 16.61 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Region (Million Liters)
Table 16.62 Global Outsourced Cell Therapy Consumables Market, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.63 Outsourced Cell Therapy Consumables Market: Distribution by Type of Consumable, 2021 and 2030
Table 16.64 Outsourced Cell Therapy Consumables Market for Kits, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.65 Outsourced Cell Therapy Consumables Market for Media, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.66 Outsourced Cell Therapy Consumables Market for Reagents, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.67 Outsourced Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2021 and 2030
Table 16.68 Outsourced Cell Therapy Consumables Market for Dendritic Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.69 Outsourced Cell Therapy Consumables Market for NK Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.70 Outsourced Cell Therapy Consumables Market for Stem Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.71 Outsourced Cell Therapy Consumables Market for T- Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.72 Outsourced Cell Therapy Consumables Market: Distribution by Scale of Operation, 2021 and 2030
Table 16.73 Outsourced Cell Therapy Consumables Market for Clinical Operations, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.74 Outsourced Cell Therapy Consumables Market for Commercial Operations, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.75 Outsourced Cell Therapy Consumables Market: Distribution by Type of End-User, 2021 and 2030
Table 16.76 Outsourced Cell Therapy Consumables Market for Industry Players, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.77 Outsourced Cell Therapy Consumables Market for Non-Industry Players, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.78 Outsourced Cell Therapy Consumables Market: Distribution by Geography, 2021 and 2030
Table 16.79 Outsourced Cell Therapy Consumables Market in North America, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.80 Outsourced Cell Therapy Consumables Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.81 Outsourced Cell Therapy Consumables Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.82 Outsourced Cell Therapy Consumables Market in Rest of the World, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report.

1. 3P Biopharmaceuticals
2. Accellta
3. Acer Therapeutics
4. Activartis Biotech
5. Adaptimmune
6. Adicet Bio
7. Aduro Biotech
8. Advent Bioservices
9. AGC Biologics
10. AgenTus Therapeutics
11. Agilent Technologies
12. Ajinomoto
13. Akadeum Life Sciences
14. Akron Biotech
15. Allele Biotechnology and Pharmaceuticals
16. Allife Medical Science and Technology
17. Allogene Therapeutics
18. Altor BioScience
19. American CryoStem
20. Amphera
21. AMSBIO
22. Anhui Kedgene Biotechnology
23. ANI Pharmaceuticals
24. apceth Biopharma
25. Applied Biological Materials
26. Arbele
27. Arcline Investment Management
28. Argos Therapeutics
29. Aspire Health Science
30. Astellas Pharma
31. Asterias Biotherapeutics
32. AstraZeneca
33. Atara Biotherapeutics
34. ATCC
35. Athersys
36. Atlantis Bioscience
37. Atreca Therapeutics
38. Aurora Biopharma
39. Austrianova
40. Autolus
41. Avantor
42. AVAX Technologies
43. Axol Bioscience
44. Basic Pharma
45. Baxalta
46. Baxter
47. BD Biosciences
48. Beijing Biohealthcare Biotechnology
49. Beijing Doing Biomedical
50. Beijing Immunochina Medical Science & Technology
51. Beijing Sanwater Biological Technology
52. Beijing Tricision Biotherapeutics 
53. Beike Biotechnology
54. Bellicum Pharmaceuticals
55. Bio Elpida
56. BioAtla
57. BioCardia
58. BioCare
59. BioCentriq
60. Bio-Connect
61. Bioinova
62. Biological Industries
63. BioNTech
64. BioRestorative Therapies
65. Bio-Techne 
66. bluebird bio
67. Bone Therapeutics
68. BrainStorm Cell Therapeutics
69. Bristol-Myers Squibb
70. C3i (Center of Excellence for Cellular Therapy)
71. Caladrius Biosciences
72. Capricor Therapeutics
73. Captain T Cell
74. CardioCell
75. Carina Biotech
76. CARsgen Therapeutics
77. CAR-T (Shanghai) Biotechnology
78. Cartherics
79. Catalent Biologics
80. Celgene
81. Celixir
82. Cell and Gene Therapy Catapult
83. Cell Applications
84. Cell Biologics
85. Cell Biotech
86. Cell Genesys
87. Cell Therapies
88. Cellaria
89. Cell-Easy
90. Cellectis
91. Cellex Cell Professionals
92. CellGenix
93. Cellin Technologies
94. Cellmed
95. CellMP (A subsidiary of Emmecell)
96. CELLnTEC Advanced Cell Systems
97. CellPraxis
98. CellProtect Nordic Pharmaceuticals
99. CellProthera
100. Cells Online
101. Cellular Biomedicine Group
102. Cellular Engineering Technologies
103. Cellular Therapeutics
104. Celonic
105. Celprogen
106. Celularity
107. Celyad
108. Censo Biotechnologies
109. CHA Biolab
110. Chengdu MedGenCell
111. China Regenerative Medicine International
112. CiMaas
113. Clean Cells
114. CO.DON
115. Cogent Biosciences
116. Cognate BioServices
117. CoImmune
118. Cook MyoSite
119. Corestem
120. Corning
121. Creative Biolabs
122. CRISPR Therapeutics
123. Cyagen Biosciences
124. Cytiva (A subsidiary of Danaher)
125. Cytopeutics
126. CytoSen Therapeutics (Acquired by Kiadis Pharma)
127. Cytovac
128. CyTuVax 
129. Daiichi Sankyo
130. DanDrit Biotech
131. DCPrime
132. Delta-Vir
133. Dendreon
134. DiscGenics
135. ElevateBio
136. Eli Lilly
137. Endocyte
138. Eureka Therapeutics
139. Eutilex
140. Ever Union Biotechnology 
141. EXUMA Biotech
142. Fate Therapeutics
143. Ferrer Internacional
144. Fibrocell Technologies
145. Five Prime Therapeutics
146. Formula Pharmaceuticals
147. Fortress Biotech
148. Fosun Kite Biotechnology
149. Froceth
150. Fujilfim Cellular Dynamics
151. Fujifilm
152. Gadeta
153. Gamida Cell
154. GC Cell (Formerly known as Green Cross Cell)
155. Gemini Bio
156. GenCure (A subsidiary of BioBridge Global)
157. Genentech
158. GenIbet Biopharmaceuticals
159. Genzyme
160. GigaGen 
161. GlaxoSmithKline
162. Global Cell Med
163. Glycostem Therapeutics
164. Gradalis
165. Green Cross
166. GRI Bio
167. Guangzhou Trinomab Biotech
168. Heat Biologics
169. Hebei Senlang Biotechnology
170. Hemostemix
171. HengRui YuanZheng Bio-Technology
172. HiMedia Laboratories
173. Histocell
174. Histogenics
175. Holostem Terapie Avanzate
176. Hunan Zhaotai Yongren Biotech
177. IBA Lifesciences
178. iCarTAB BioMed
179. iCell Gene Therapeutics
180. Immatics
181. Immune Therapeutics
182. Immunicum
183. ImmunoCellular Therapeutics
184. Immunocore
185. Immunovative Therapies 
186. Immutep
187. IncoCell Tianjin (wholly-owned subsidiary of Boyalife Group)
188. Incysus
189. Innoprot
190. Innovative Cellular Therapeutics
191. Inovio Pharmaceuticals
192. inRegen
193. Intellia Therapeutics
194. International Stem Cell Corporation
195. InVitria
196. Iovance Biotherapeutics
197. Irvine Scientific (Acquired by FUJIFILM)
198. ISTO Technologies
199. Ivy Life Sciences
200. iXCells Biotechnologies
201. Janssen
202. Japan Tissue Engineering
203. Juno Therapeutics
204. JW Biotechnology
205. JW CreaGene
206. Kadimastem
207. Kangstem Biotech
208. KBI Biopharma
209. Kiadis Pharma
210. Kiromic
211. Kite Pharma
212. Kuur Therapeutics
213. LAgen Laboratories
214. Laurus Bio (Formerly known as Richcore Lifesciences)
215. Laurus Labs
216. Legend Biotech
217. Leucid Bio
218. Lifecells
219. Lineage Cell Therapeutics
220. Lion TCR
221. Living Pharma
222. Longeveron
223. Lonza
224. Lumos Pharma
225. Lykan Bioscience
226. Marino Biotechnology
227. MaxCyte
228. Medeor Therapeutics
229. Medigene
230. MEDINET
231. MEDIPOST
232. MedVax Technologies
233. Merck Serono
234. Mesoblast
235. Miltenyi Biotec
236. Minaris Regenerative Medicine
237. Minerva Biotechnologies
238. Minovia Therapeutics
239. MolecuVax
240. Moraga Biotechnology
241. Multimmune
242. Mustang Bio 
243. Nanjing KAEDI Biotech
244. NantKwest
245. Neopharm
246. Neuralstem
247. Neuromics
248. Nikon CeLL innovation
249. Nkarta
250. Nohla Therapeutics
251. Noile-Immune Biotech
252. Northern Therapeutics
253. Northwest Biotherapeutics
254. Novadip Biosciences
255. Novartis
256. NovaRx (Acquired by Viropro)
257. Novella Clinical
258. Novex Innovations
259. Nucleus Biologics
260. Nuo Therapeutics
261. OhioHealth
262. OiDE BetaRevive
263. Ology Bioservices
264. Oncobiomed
265. Opexa Therapeutics
266. Orchard Therapeutics
267. OrganaBio
268. Osiris Therapeutics
269. Oxford BioMedica
270. PAN-Biotech
271. PDC*line Pharma
272. PELOBiotech
273. PeproTech
274. PersonGen BioTherapeutics
275. Pfizer
276. PharmaBio
277. Pharmicell
278. PhoenixSongs Biologicals
279. Pinze Lifetechnology
280. Pique Therapeutics
281. Pluristem Therapeutics
282. Plus Therapeutics
283. Poseida Therapeutics
284. Precigen
285. Precision BioSciences
286. Preferred Cell Systems™
287. Pregene ShenZhen Biotechnology
288. Primorigen Biosciences (Acquired by Nucleus Biologics)
289. ProMab Biotechnologies
290. Promethera Biosciences
291. PromoCell
292. Provia Laboratories
293. R&D Systems (Formerly known as Atlanta Biologicals)
294. ReachBio Research Labs
295. Regeneris Medical
296. Regeneron
297. Regeneus
298. ReNeuron
299. REPROCELL
300. Rexgenero
301. RHEACELL
302. Riyadh Pharma
303. RoosterBio
304. Roslin Cell Therapies
305. Rubius Therapeutics
306. S.Biomedics
307. Sangamo Therapeutics
308. Sanvitra
309. Saronic Biotechnology
310. Sartorius
311. ScienCell Research Laboratories
312. Sclnow Biotechnology
313. SCM Lifescience
314. Seattle Genetics
315. Sentien Biotechnologies
316. Servier
317. Shanghai Bioray Laboratory
318. Shanghai GeneChem
319. Shanghai Houchao Biotechnology
320. Shanghai iCELL Biotechnology
321. Shanghai Longyao Biotechnology
322. Shanghai Unicar-Therapy Bio-medicine Technology
323. Shenzhen BinDeBio
324. Shenzhen Hornetcorn Biotechnology
325. Shionogi
326. Sigma-Aldrich (Acquired by Merck)
327. Sinobioway Cell Therapy
328. SMT Bio
329. Sorrento Therapeutics
330. SOTIO
331. SQZ Biotech
332. Stem Cell Arabia
333. STEMCELL Technologies
334. StemImmune
335. Stemmatters 
336. Sumitomo Dainippon Pharma
337. Super-T Cell Cancer Company
338. Surface Oncology
339. Tactiva Therapeutics
340. Taiwan Bio Therapeutics
341. Takara Bio
342. Takeda Pharmaceutical
343. TapImmune 
344. Targazyme
345. TC BioPharm
346. TCR2 Therapeutics
347. Tella
348. Tessa Therapeutics
349. The Discovery Labs Center for Breakthrough Medicines
350. Thermo Fisher Scientific
351. ThermoGenesis
352. Tianhe Stem Cell Biotechnologies
353. TiGenix
354. TILT Biotherapeutics
355. Tmunity Therapeutics
356. TNK Therapeutics
357. TotipotentRX
358. TRACT Therapeutics
359. TransCure BioServices
360. TreeFrog Therapeutics
361. Trinova Biochem
362. Triumvira Immunologics
363. TVAX Biomedical
364. Universal Cells
365. U.S. Stem Cell
366. Vaccinogen
367. Vericel
368. VetStem Biopharma
369. ViroMed
370. Viscofan BioEngineering
371. Vitro Biopharma
372. Waisman Biomanufacturing
373. West Biotherapy
374. Wissenschaftlicher Service Pharma (WiSP)
375. Wuhan Sian Medical Technology
376. WuXi AppTec (WuXi Advanced Therapies)
377. Xcell Therapeutics
378. Xcelthera
379. XEME Biopharma
380. Zelluna Immunotherapy 
381. Zimmer Biomet
382. Ziopharm Oncology